Back to Index

AVONMORE Daily Market Report

Date Range: 2023-01-04 to 2026-10-26 | Evidence Type: Daily-only

DAILY-ONLY FALLBACK: This security has current daily OHLCV history but lacks the intraday files required by the legacy execution simulator. The page therefore reports observable daily-market evidence and current research candidates only. It does not claim intraday backtest performance or a trading recommendation.

Current Snapshot

Current Snapshot — AVONMORE Report
Metric Value
Latest closed session 2026-10-26
Latest close 11.5500
20-session average turnover 3047941.18
Distance from 252-session high -40.43%

Trailing Price Returns

Trailing Price Returns — AVONMORE Report
Sessions Return
1 -3.02%
5 -9.84%
20 -11.83%
60 5.19%
120 -5.33%
250 -35.22%

These are trailing observations ending on the latest closed session, not forward returns from a setup.

Current Market Intelligence Candidates

Current Market Intelligence Candidates — AVONMORE Report
Archetype Regime Primary horizon Strength First rejection risk
MEAN_REVERSION_CAPITULATION BEAR_PERSISTENT 20 2.21 Continued trend momentum breakdown
PRICE_DISLOCATION BEAR_PERSISTENT 120 0.19 Continued price deterioration or adverse fundamental evidence

Evidence Limits

Fundamental Research

Fundamental Research — AVONMORE Report
Field Value
Statement scope FULL_STATEMENTS
Latest annual period 2026-03-31
Statement completeness 100%
Revenue growth -2.19%
Net margin 4.54%
Return on equity 2.04%
Debt/equity 0.06
Operating cash flow/net income 0.12
Free-cash-flow margin -0.61%
Trailing P/E 20.54
Price/book 0.80

Source: EODHD retrieved 2026-10-13T23:39:55.397815+00:00.

QA flags: balance_sheet_equation: difference=1187000000.00; weak_cash_conversion: operating cash flow/net income below 0.5

Missing statements mean data is unavailable. Balance-sheet equation flags require checking accounting definitions and units. Weak cash conversion and high leverage are financial risk observations, not necessarily data errors. A summary-only record cannot establish financial quality.

Provider-standardized figures are a research aid. Review consolidated filings, units, restatements, accounting policies, and QA flags before investment use.